AU1776701A - Solid state forms of 5-((6-((2-fluorophenyl)methoxy)-2-naphthalenyl)methyl)-2,4- thiazolidinedione - Google Patents

Solid state forms of 5-((6-((2-fluorophenyl)methoxy)-2-naphthalenyl)methyl)-2,4- thiazolidinedione

Info

Publication number
AU1776701A
AU1776701A AU17767/01A AU1776701A AU1776701A AU 1776701 A AU1776701 A AU 1776701A AU 17767/01 A AU17767/01 A AU 17767/01A AU 1776701 A AU1776701 A AU 1776701A AU 1776701 A AU1776701 A AU 1776701A
Authority
AU
Australia
Prior art keywords
thiazolidinedione
naphthalenyl
fluorophenyl
methoxy
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17767/01A
Inventor
Mark C. Andres
Stephen R. Bryn
Ann W. Newman
Catherine Russell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of AU1776701A publication Critical patent/AU1776701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AU17767/01A 1999-11-19 2000-11-17 Solid state forms of 5-((6-((2-fluorophenyl)methoxy)-2-naphthalenyl)methyl)-2,4- thiazolidinedione Abandoned AU1776701A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16651599P 1999-11-19 1999-11-19
US60166515 1999-11-19
PCT/US2000/031705 WO2001036401A1 (en) 1999-11-19 2000-11-17 Solid state forms of 5-[[6-[(2-fluorophenyl)methoxy]-2-naphthalenyl]methyl]-2,4-thiazolidinedione

Publications (1)

Publication Number Publication Date
AU1776701A true AU1776701A (en) 2001-05-30

Family

ID=22603643

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17767/01A Abandoned AU1776701A (en) 1999-11-19 2000-11-17 Solid state forms of 5-((6-((2-fluorophenyl)methoxy)-2-naphthalenyl)methyl)-2,4- thiazolidinedione

Country Status (16)

Country Link
EP (1) EP1235817A1 (en)
JP (1) JP2003514807A (en)
CN (1) CN1423639A (en)
AR (1) AR029409A1 (en)
AU (1) AU1776701A (en)
BG (1) BG106692A (en)
BR (1) BR0015702A (en)
CA (1) CA2391429A1 (en)
HU (1) HUP0203280A3 (en)
IL (1) IL149593A0 (en)
MX (1) MXPA02005008A (en)
NO (1) NO20022329L (en)
RU (1) RU2002113123A (en)
WO (1) WO2001036401A1 (en)
YU (1) YU35602A (en)
ZA (1) ZA200204873B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104055774A (en) * 2013-03-22 2014-09-24 天津药物研究院 Stable amorphous pioglitazone hydrochloride compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594016A (en) * 1992-12-28 1997-01-14 Mitsubishi Chemical Corporation Naphthalene derivatives
JP2845743B2 (en) * 1992-12-28 1999-01-13 三菱化学株式会社 New naphthalene derivatives
JP4023697B2 (en) * 1996-11-14 2007-12-19 三菱化学株式会社 Method for producing naphthalene derivative
PL348502A1 (en) * 1998-11-20 2002-05-20 Mitsubishi Chem Corp Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione

Also Published As

Publication number Publication date
MXPA02005008A (en) 2003-10-14
CA2391429A1 (en) 2001-05-25
BR0015702A (en) 2002-07-16
HUP0203280A3 (en) 2003-07-28
IL149593A0 (en) 2002-11-10
EP1235817A1 (en) 2002-09-04
HUP0203280A2 (en) 2003-01-28
CN1423639A (en) 2003-06-11
AR029409A1 (en) 2003-06-25
WO2001036401A1 (en) 2001-05-25
NO20022329L (en) 2002-07-09
RU2002113123A (en) 2004-01-20
YU35602A (en) 2006-05-25
ZA200204873B (en) 2003-11-26
JP2003514807A (en) 2003-04-22
NO20022329D0 (en) 2002-05-15
BG106692A (en) 2003-03-31

Similar Documents

Publication Publication Date Title
EP1276738B8 (en) 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
AU1978699A (en) Heterocyclic compounds
AU2001262150A1 (en) 2-(nitrogen-heterocyclic)pyrimidone derivatives
AUPP818099A0 (en) New n-containing heterocyclic compounds
AU2002228692A1 (en) 3-(2,4-dimethylthiazol-5-yl) indeno(1,2-c)pyrazol-4-one derivatives as cdk inhibitors
IT1319999B1 (en) ASSEMBLY GROUP FOR SLIDING SLING-TONGUE OF A LAMPO HINGE.
AU4395399A (en) Five-membered heteroaryl compounds
ZA972973B (en) Substituted [2-(1-piperazinyl)ethoxy]methyl compounds.
AU2002232468A1 (en) Pharmaceutical heterocyclic compounds
AU2231397A (en) Thiazolidine-2,4-dione derivatives
AU2002352357A1 (en) Trioxane derivatives
AU2001258841A1 (en) Heterocyclic compounds
AU2001293207A1 (en) Nitrogenous heterocyclic compounds
AU6059999A (en) 2-substituted heterocyclic sulfonamides
NO20006350D0 (en) Derivatives of 3- (2-oxo- [1,3 '] bipyrrolidinyl-3-ylidene methyl) cephemer
AU1776701A (en) Solid state forms of 5-((6-((2-fluorophenyl)methoxy)-2-naphthalenyl)methyl)-2,4- thiazolidinedione
AU2002359160A1 (en) PIPAZOLO (1,5-a) PYRIMIDINE DERIVATIVES AS MODULATORS OF PPAR
AU2453900A (en) 1-((indoly azacycloalkyl) alkyl)-2,1, 3-benzothiadiazole 2,2-dioxides exhibiting5-ht2a receptor activity
AUPP921299A0 (en) New heterocyclic compounds
HUP0104139A3 (en) Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione
AU2356301A (en) Silylated heterocyclic compounds
AU2001236048A1 (en) Oxygen-containing heterocyclic compounds
HUP0103517A3 (en) Improved process for the preparation of thiazolidine-2,4-dione derivatives
AU7961800A (en) Thiazolidinedione derivatives
AU2001296424A1 (en) Universal temperature compensation application specific integrated circuit

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase